Jones Trading lowered shares of Theratechnologies (TSE:TH - Free Report) from a strong-buy rating to a hold rating in a research report sent to investors on Thursday morning,Zacks.com reports.
Theratechnologies Price Performance
Shares of TH stock traded up C$0.15 during mid-day trading on Thursday, hitting C$4.33. 223,219 shares of the stock were exchanged, compared to its average volume of 94,333. The company has a market cap of C$138.15 million, a PE ratio of -49.01, a price-to-earnings-growth ratio of -8.50 and a beta of 1.73. Theratechnologies has a 52-week low of C$1.59 and a 52-week high of C$4.34. The firm has a fifty day moving average of C$3.60 and a 200 day moving average of C$2.91. The company has a quick ratio of 0.64, a current ratio of 1.08 and a debt-to-equity ratio of -293.92.
Theratechnologies Company Profile
(
Get Free Report)
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States.
Further Reading
Before you consider Theratechnologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Theratechnologies wasn't on the list.
While Theratechnologies currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.